Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI
Book tickets
Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI
Current Landscape and Challenges
NHS screening programmes are central to the shift towards prevention and early diagnosis, yet delivery at scale remains inconsistent. Rising demand, workforce shortages and increasing diagnostic backlogs are placing significant strain across imaging, pathology and community screening services.
At the same time, systems are being asked to expand access, reduce inequalities and accelerate diagnosis across key pathways including cancer, cardiovascular and long term conditions. Screening programmes such as breast and cervical are under increasing pressure to improve uptake, turnaround times and diagnostic accuracy while maintaining public trust and clinical safety.
Fragmented data flows, limited interoperability and variable digital maturity continue to slow progress. The introduction of AI into screening pathways presents a significant opportunity, but also introduces new challenges around governance, workforce confidence and safe deployment at scale.
The challenge is no longer understanding what needs to change, but how to implement integrated, AI enabled and workforce sustainable screening models across imaging, pathology and population health systems.
Timeliness of the Event
With national focus intensifying on prevention, early detection and population health management, screening is now a critical lever for improving outcomes and reducing pressure on acute services.
AI enabled diagnostics, community diagnostic centres and targeted screening initiatives are already being deployed across the NHS, particularly within high impact areas such as breast and cervical screening. However, variation in adoption, pathway design and operational delivery remains significant.
There is a clear need to move beyond pilots and isolated innovation towards standardised, system wide implementation. This includes aligning imaging, pathology and digital infrastructure, while ensuring governance, safety and workforce readiness are embedded from the outset.
Screening360 2026 provides a timely platform for NHS leaders to understand what is working in practice, learn from early adopters and accelerate the delivery of scalable, equitable and clinically robust screening services.
Key Learning Outcomes
- How to implement AI enabled screening workflows across imaging and pathology while maintaining clinical safety and governance.
- Practical delivery models for high impact screening pathways including breast, cervical and cancer diagnostics.
- Approaches to integrating imaging, pathology and data systems to support faster and more accurate diagnosis.
- How to expand screening capacity through community based and population health driven models.
- Workforce strategies including skill mix, automation and decision support to increase throughput without increasing burnout.
- Governance frameworks required to deploy AI safely, manage risk and build clinical and public confidence.
- Lessons learned from NHS organisations moving from pilot to operational screening delivery at scale.
Why Attend
Screening360 2026 is designed for NHS leaders responsible for delivering screening and diagnostic transformation across real world pathways. This is not a high level policy discussion, it is a practical forum focused on how to operationalise screening at scale.
With a strong focus on high impact areas such as cancer screening and women’s health pathways, the event brings together imaging, pathology and digital leaders to share what is working, what has failed and what needs to change.
Delegates will leave with tangible outputs including implementation frameworks, governance checklists and real world delivery models that can be applied immediately within their own systems. Through skill clinics, NHS deep dives and frontline reflections, attendees will gain the clarity and confidence needed to expand capacity, improve early detection and deliver measurable improvement in patient outcomes.
Sponsors & Partners
Your Pass Includes....
- This conference is CPD accredited. Attendees will be eligible to gain 8 CPD points upon completion of the event.
- Access to a leading conference speaker programme
- Interactive Q&A sessions
- Leadership Lessons from the Front Line
- Cross-sector best practice
- Meet the supplier opportunities
- Hot breakfast & Lunch included
- Access to post event drinks reception and Street food
Tickets For NHS Senior Managers
We have an invite only option for NHS Senior Managers for our conference, to see if you qualify for a complimentary place please click the button below.
The programme
Registration & Networking
Registration - Open from 8:20 am - Closes at 11:00 am
All delegates must complete their registration process before the 11:00 AM cut-off time. Please arrive in a timely manner to allow for registration and to avoid any inconvenience. Delegates who arrive after the registration deadline will be refused entry to the event.
We appreciate your cooperation in helping us maintain the event's schedule and ensuring that everyone can fully participate in the conference. If you have any questions or require assistance, our event staff will be available to assist you with the registration process.
Thank you for your understanding, and we look forward to an insightful and productive event together!
Keynote Presentation - Rethinking Screening: Early Detection, Undiagnosed Disease and the Future of Prevention in the NHS
Session Overview:
Screening is no longer limited to traditional cancer pathways. Across the NHS, a growing proportion of patients with conditions such as liver disease, metabolic disorders and alcohol-related harm continue to present late, placing significant pressure on acute services and limiting opportunities for early intervention.
This keynote will provide a system-wide clinical perspective on how screening and case finding must evolve to support earlier detection, prevention and population health. Drawing on frontline experience, the session will explore how services can move beyond siloed models towards more integrated, proactive approaches across multiple conditions.
Key Learning:
- The scale and impact of undiagnosed disease across the NHS.
- The role of screening and case finding in prevention and early intervention.
- How pathways need to evolve beyond traditional screening models.
- The link between early detection, population health and system sustainability.
Speaker:
- Professor Kevin Moore, Professor of Hepatology, Royal Free London NHS Foundation Trust
Morning Knowledge Exchange Session - Digital Pathology and AI in Screening: From Pilot Design to Real-World Implementation (TBC)
Session Overview:
Digital pathology and AI are increasingly positioned as key enablers of scalable screening, yet many NHS services remain at an early stage of adoption.
This practical session will explore how AI is being introduced into screening pathways, using emerging programmes such as the ImProve prostate cancer screening trial as a real-world case study. The session will focus on how these models are being designed, where AI is expected to support clinical decision-making and what is required to move from pilot into operational delivery.
Rather than focusing on theory, this session will provide an honest view of where implementation currently stands, what is still evolving and what NHS organisations should be preparing for.
Key Learning:
- The role of digital pathology and AI within emerging screening programmes.
- How initiatives such as the ImProve trial are shaping future screening models.
- Early lessons from introducing AI into diagnostic workflows.
- What is required to move from pilot to scalable NHS delivery.
Speakers:
- Iskander Chaudhry, Consultant (Pathology), South Tees Hospitals NHS Foundation Trust
Main Sponsor
Main Sponsor
Case Study
Case Study
Case Study
Case Study
Lessons Learnt from the Frontline - From Pilot to Practice: What Actually Happens When You Scale Screening (TBC)
Session Overview:
An honest reflection from NHS leaders who have implemented screening transformation programmes. This session focuses on what worked, what didn’t and what needed to change when moving from pilot to operational delivery.
Too often, early success in pilot environments does not translate into sustainable service models. This session will explore the real challenges encountered during scale up, including workforce resistance, pathway redesign, governance barriers and operational constraints.
Key Learning:
- Common pitfalls when scaling screening services and how to avoid them.
- What successful implementation looks like in practice.
- How teams adapted workforce models, workflows and governance.
Case Study
Case Study
Case Study
Case Study
NHS Deep Dive - Expanding Screening Capacity Without Expanding Workforce: A Practical NHS Approach
Session Overview:
With workforce growth constrained, services are under increasing pressure to deliver higher screening volumes without increasing staff burden.
This session explores how organisations are redesigning workforce models, introducing advanced practice roles and using decision support to increase capacity. Drawing on real-world experience from cancer pathways, the focus is on improving throughput while maintaining staff wellbeing and clinical safety.
Key Learning:
- Workforce models that support higher volume screening delivery.
- The role of advanced practice and skill mix redesign.
- How services are balancing productivity with workforce wellbeing.
- Practical examples of pathway redesign in cancer screening.
Speaker:
- Marisa Lima, Lead Nurse for Cancer, Barts Health NHS Trust
Case Study
Case Study
NHS Deep Dive - From Detection to Decision: Improving Early Diagnosis in Lung Cancer Pathways
Session Overview:
As imaging identifies increasing numbers of pulmonary nodules, the challenge is no longer detection alone, but how quickly and effectively patients move through diagnostic and treatment pathways.
This session explores the role of imaging within lung cancer screening and early diagnosis, highlighting where pathways work well and where delays, fragmentation and inefficiencies remain. With a focus on real clinical practice, it will examine how stronger integration between imaging, diagnostics and surgical decision-making can improve outcomes.
Key Learning:
- The growing role of imaging in early cancer detection.
- Challenges in translating detection into timely diagnosis and treatment.
- Where delays occur across current diagnostic pathways.
- Practical approaches to improving speed, accuracy and clinical decision-making.
Speaker:
- Pavlos Papoulidis, Consultant Thoracic Surgeon, University Hospitals of Leicester NHS Trust
Afternoon Skills Clinic - Building Safe, Governed and Trusted AI Enabled Screening Services (TBC)
Session Overview:
This practical clinic focuses on governance, safety and trust in AI enabled screening. Delegates will explore how to manage risk, ensure compliance and build confidence among clinicians and patients.
As AI becomes more embedded within screening pathways, maintaining transparency and accountability is critical. This session will provide practical guidance on how to implement governance frameworks that support safe innovation while maintaining public and clinical trust.
Key Learning:
- Governance frameworks for AI in screening services.
- Managing risk, bias and clinical safety.
- How to build trust with clinicians and the public.
Book your tickets
Limited places
Limited places
Limited places
